A1ZN34:BVMF
Astrazeneca Plc Bdr
141,91 BRL
0,00%
(0,00) 1 D.
10-15, 21:31:36 GMT−3 · BRL
search
Visi simboliai
| Simbolis | Kaina | Keisti | Pokytis, % |
|---|
insights_autoGeneruojamos svarbiausios „A1ZN34“ įžvalgos...
Atidaryti
137,84 BRL
Aukšta
142,91 BRL
Žema
137,84 BRL
Rinkos kapitalizacija
192,19 mlrd.
Vid. kiekis
875,00
Apimtis
0,00
52 sav. aukšta
190,40 BRL
52 sav. žema
129,06 BRL
Neapmokėtos akcijos
1,55 mlrd.
Darbuotojų skaičius
96 tūkst.
Atidaryti
137,84 BRL
Aukšta
142,91 BRL
Žema
137,84 BRL
Rinkos kapitalizacija
192,19 mlrd.
Vid. kiekis
875,00
Apimtis
0,00
52 sav. aukšta
190,40 BRL
52 sav. žema
129,06 BRL
Neapmokėtos akcijos
1,55 mlrd.
Darbuotojų skaičius
96 tūkst.
Naujienų istorijos
Iš žiniatinklio šaltinių ir naujienų partnerių
JournalArta
·
prieš 7 valandas
AstraZeneca Stock Analysis: Gains 3.24%, Testing Key Resistance
Reuters
·
prieš 10 valandų
AstraZeneca strikes $40 million AI drug discovery deal with insitro
Fox Business
·
prieš 13 valandų
AstraZeneca, Insitro strike AI drug discovery deal
TradingKey
·
prieš 17 valandų
AstraZeneca PLC Stock (AZN) Moved Up by 3.55% on Oct 15: What Signal Does It Send?
Profilis
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
Apie „Astrazeneca Plc Bdr“
Generalinis direktoriusPascal Soriot
Darbuotojai96,1 tūkst.
Įkurta1999-04-06
Pagrindinė būstinėKembridžas, Keimbridžšyras, Jungtinė Karalystė
Sektorius-
Svetainėastrazeneca.com